Radioimmunoassay and the hormones of thyroid function.
Radioimmunoassay (RIA) has provided the tools for wide-reaching investigations that have changed and continue to change many important concepts of thyroid physiology and pathosphysiology. The RIA vor human thyrotropin (TSH) was developed in 1965; development of the RIA for triiodothyronine (T3), thyroxine (T4), thyroxine-binding globulin (TBG), and, recently, thyrothropin-releasing hormone (TRH) and thyroglobulin (Tg) followed. The capacity to measure nanogram and picogram concentrations with relative ease and speed has permitted the demonstration of dynamic relationships of the intrathyroidal and circulating thyroid hormones to each other and to the pituitary and hypothalamic regulating hormones. Evidence for the presence of cross-influences between TRH and other hypothalamic regulating hormones on the secretion of pituitary hormones has accumulated. The impact of the new information on clinical practice is now becoming evident. There is new appreciation of the value of assaying serum T3 and TSH concentrations in the clinical management of patients with disturbed function of the thyroid, pituitary, or hypothalamus. The necessary components for RIA performance can be purchansed separately or in kit form from commercial sources. With appropriate quality-control procedures, precise, sensitive, and reliable data can be generated. Awareness of the specific technical problems relating to the RIA of these hormones is absolutely necessary to assure reliable results. The availability of kits or their components permits the performance of these studies in the community hospital and in reliable commercial-service laboratories.
D000172:Acromegaly / Q000097:blood; D000238:Adenoma, Chromophobe / Q000097:blood; D001769:Blood; D002116:Calcitonin / Q000097:blood; D002822:Choriocarcinoma / Q000097:blood; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D006042:Goiter / Q000097:blood; D013006:Growth Hormone / Q000494:pharmacology; D006801:Humans; D006828:Hydatidiform Mole / Q000097:blood; D006980:Hyperthyroidism / Q000097:blood; D007018:Hypopituitarism / Q000097:blood; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy; D007231:Infant, Newborn; D007676:Kidney Failure, Chronic / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood; D008135:Long-Acting Thyroid Stimulator / Q000494:pharmacology; D008297:Male; D008598:Menstruation; D011247:Pregnancy; D011388:Prolactin; D011863:Radioimmunoassay / Q000379:methods; D013004:Somatostatin / Q000494:pharmacology; D013964:Thyroid Neoplasms / Q000097:blood; D013967:Thyroiditis, Autoimmune / Q000097:blood; D013972:Thyrotropin / Q000037:antagonists & inhibitors / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000097:blood* / Q000494:pharmacology; D013974:Thyroxine / Q000097:blood*; D013975:Thyroxine-Binding Proteins / Q000032:analysis; D014284:Triiodothyronine / Q000097:blood*
D005938:Glucocorticoids; D013975:Thyroxine-Binding Proteins; D014284:Triiodothyronine; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013972:Thyrotropin; D013006:Growth Hormone; D002116:Calcitonin; D008135:Long-Acting Thyroid Stimulator; D013974:Thyroxine